Colgate-Palmolive (NYSE:CL) Stock Position Lowered by BBR Partners LLC

BBR Partners LLC lowered its position in shares of Colgate-Palmolive (NYSE:CL) by 60.5% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 2,353 shares of the company’s stock after selling 3,597 shares during the period. BBR Partners LLC’s holdings in Colgate-Palmolive were worth $214,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently bought and sold shares of the company. Kohmann Bosshard Financial Services LLC bought a new position in shares of Colgate-Palmolive in the fourth quarter valued at $26,000. Centricity Wealth Management LLC acquired a new stake in shares of Colgate-Palmolive during the fourth quarter worth $27,000. Union Bancaire Privee UBP SA acquired a new stake in shares of Colgate-Palmolive during the fourth quarter worth $32,000. Bernard Wealth Management Corp. purchased a new stake in shares of Colgate-Palmolive during the fourth quarter valued at $36,000. Finally, Roxbury Financial LLC acquired a new position in shares of Colgate-Palmolive in the 4th quarter valued at $43,000. 80.41% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of analysts have commented on CL shares. Barclays reduced their price objective on shares of Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating for the company in a research note on Friday, January 17th. Stifel Nicolaus reduced their price target on shares of Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating for the company in a research report on Monday, February 3rd. Piper Sandler lowered their price objective on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a research report on Monday, January 6th. UBS Group reduced their target price on Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating for the company in a report on Monday, February 3rd. Finally, Morgan Stanley decreased their target price on Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating for the company in a research report on Monday, February 3rd. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and twelve have given a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $101.61.

Colgate-Palmolive Price Performance

NYSE CL opened at $96.84 on Friday. The company has a 50 day moving average price of $88.84 and a two-hundred day moving average price of $95.22. Colgate-Palmolive has a 12-month low of $85.32 and a 12-month high of $109.30. The stock has a market capitalization of $78.59 billion, a PE ratio of 27.51, a price-to-earnings-growth ratio of 4.20 and a beta of 0.40. The company has a quick ratio of 0.58, a current ratio of 0.92 and a debt-to-equity ratio of 13.40.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same period in the previous year, the firm earned $0.87 earnings per share. As a group, equities analysts predict that Colgate-Palmolive will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, February 14th. Investors of record on Tuesday, January 21st were paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.07%. The ex-dividend date was Tuesday, January 21st. Colgate-Palmolive’s payout ratio is 56.82%.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.